Related Experiment Video
Updated: Apr 6, 2026

Lentiviral Vector-mediated Gene Therapy of Hepatocytes Ex Vivo for Autologous Transplantation in Swine
Published on: November 4, 2018
Correction of factor XI deficiency by liver transplantation
Eva Gupta1, Laura Finn, Gretchen Johns
1aDivision of Hematology and Oncology bDivision of Laboratory Medicine and Pathology, -Jacksonville, Florida cDivision of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Abstract:
Orthotopic liver transplantation for other diseases typically results in a coincidental cure for hemophilia A and B; however, long-term outcomes of liver transplant in hemophilia C are not very well described. Herein, the authors report a patient of severe congenital factor XI (FXI) deficiency who received an orthotopic liver transplant. The authors discuss the perioperative management and long-term outcomes. The normalization of his FXI levels confirms that the liver is the most clinically relevant site of synthesis of FXI.

